IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinomaYuichiro Matsuoka, Ryuji Murakami, Hideki Nakayama et al.|British Journal of Cancer|2016Cited by 127
The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinomaYuichiro Matsuoka, Masanori Shinohara, Ryoji Yoshida et al.|Apmis|2014Cited by 67
Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective studyHikaru Nakashima, Hideki Nakayama, Yuichiro Matsuoka et al.|BMC Cancer|2016Cited by 62
Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cellsYoshihiro Nakagawa, Masanori Shinohara, Hideki Nakayama et al.|International Journal of Oncology|2014Cited by 57
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axisK. Yamana, Hideki Nakayama, Rin Liu et al.|Journal of Extracellular Vesicles|2021Cited by 44